Dear Users,

The journal ratings for Impact Factor 2024 have been published.

https://jcr.clarivate.com

Molnár-Fodor Klára

University of Debrecen Faculty of Pharmacy

Department of Biopharmacy

2017-

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2013-2021

2021

Fodor, P., Molnár-Fodor, K., Zsebik, B., Szabó, Z., Dobos, N., Schally, A. V., Halmos, G.: Angiogenezisgátló célzott terápiás VEGF-inhibitor és citotoxikus peptidhormon-analóg kombinált alkalmazásának vizsgálata uvealis melanomában in vitro.
Magyar Onkol. 65 (Suppl.), 19, 2021.

DEA

Szabó, Z., Dezső, B., Molnár-Fodor, K., Szegedi, K., Flaskó, T., Szabó, E., Oláh, G., Sipos, É., Dobos, N., Gardi, J., Schally, A. V., Halmos, G.: Expression of Luteinizing Hormone-Releasing Hormone (LHRH) and Type-I LHRH Receptor in Transitional Cell Carcinoma Type of Human Bladder Cancer.
Molecules. 26 (5), 1-14, (article identifier: 1253), 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q2 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

2020

Molnár-Fodor, K., Sipos, É., Dobos, N., Nagy, J., Steiber, Z., Méhes, G., Dull, K., Székvölgyi, L., Schally, A. V., Halmos, G.: Correlation between the Expression of Angiogenic Factors and Stem Cell Markers in Human Uveal Melanoma.
Life (Basel). 10 (12), 1-15, (article identifier: 310), 2020.

doi DEA

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Ecology, Evolution, Behavior and Systematics

Q1 Paleontology

Q2 Space and Planetary Science

Molnár-Fodor, K., Dobos, N., Nagy, J., Méhes, G., Halmos, G.: Correlations between the Expression of Angiogenic Factors and Stem Cell Markers in Human Uveal Melanoma.
In: 4th National Conference of Young Biotechnologists : Abstract Book "FIBOK 2020" / publ. University of Debrecen, University of Debrecen, Debrecen, 56, 2020.

DEA

Molnár-Fodor, K., Dobos, N., Schally, A. V., Steiber, Z., Oláh, G., Sipos, É., Székvölgyi, L., Halmos, G.: The targeted LHRH analog AEZS-108 alters expression of genes related to angiogenesis and development of metastasis in uveal melanoma.
Oncotarget. 11 (2), 175-187, 2020.

doi DEA

Journal metrics:

Q2 Oncology

Molnár-Fodor, K., Dobos, N., Schally, A. V., Steiber, Z., Halmos, G.: The targeted LHRH analog AEZS-108 alters expression of genes related to angiogenesis and development of metastasis in uveal melanoma.
In: 4th National Conference of Young Biotechnologists : Abstract Book "FIBOK 2020" / publ. University of Debrecen, University of Debrecen, Debrecen, 50, 2020.

DEA

2018

Sipos, É., Dobos, N., Rózsa, D., Molnár-Fodor, K., Oláh, G., Szabó, Z., Székvölgyi, L., Schally, A. V., Halmos, G.: Characterization of Luteinizing hormone-releasing hormone (LH-RH-I) receptor type I as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines.
OncoTargets Ther. 11, 933-941, 2018.

doi DEA

Journal metrics:

Q2 Oncology

Q2 Pharmacology (medical)

Oláh, G., Dobos, N., Vámosi, G., Szabó, Z., Sipos, É., Molnár-Fodor, K., Harda, K. M., Schally, A. V., Halmos, G.: Experimental therapy of doxorubicin resistant human uveal melanoma with targeted cytotoxic luteinizing hormone-releasing hormone analog (AN-152).
Eur. J. Pharm. Sci. 123, 371-376, 2018.

doi DEA

Journal metrics:

Q1 Pharmaceutical Science

Harda, K. M., Szabó, Z., Szabó, E., Oláh, G., Molnár-Fodor, K., Szász, C. S., Méhes, G., Schally, A. V., Halmos, G.: Somatostatin Receptors as Molecular Targets in Human Uveal Melanoma.
Molecules. 23 (7), 1-13, (article identifier: 1535), 2018.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q1 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

2017

10.

Sipos, É., Dull, K., Treszl, A., Steiber, Z., Méhes, G., Dobos, N., Molnár-Fodor, K., Oláh, G., Székvölgyi, L., Schally, A. V., Halmos, G.: Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.
Oncol. Rep. 37, 1927-1934, 2017.

doi DEA

Journal metrics:

Q3 Cancer Research

Q1 Medicine (miscellaneous)

Q2 Oncology

2013

11.

Molnár-Fodor, K.: Az AN-152 (AEZS-108) célzott daganatterápiás készítmény hatásmechanizmusának vizsgálata.
In: "A mi tendenciáink..." Szakkollégiumi Tanulmányok, 2. : Hatvani István Szakkollégium Debreceni Egyetem Tudományegyetemi Karok. Szerk.: Dorogi Zoltán, Uri Dénes Mihály, Debreceni Egyetem Tudományegyetemi Karok Hatvani István Szakkollégiuma, Debrecen, 161-168, 2013, 2063-6059

DEA

12.

Treszl, A., Steiber, Z., Schally, A. V., Block, N. L., Dezső, B., Oláh, G., Rózsa, B., Molnár-Fodor, K., Buglyó, A., Gardi, J., Berta, A., Halmos, G.: Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma.
Oncotarget. 4 (10), 1721-1728, 2013.

DEA

Journal metrics:

D1 Oncology